Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
Phenytoin, a drug that blocks sodium channels on the membranes of cells, may have implications on breast cancer cells. Previously, phenytoin was only used as a drug to treat epilepsy, ... Read more
Many patients with breast cancer choose to undergo breast reconstruction following mastectomy. For some women over the age of 65, there has been concern for an increased risk of complications, ... Read more
Breast cancer is a problem best solved by a multidisciplinary team. As such, a collaboration between biologists, physicists, and engineers at Georgetown Lombardi Comprehensive Cancer Center and Virginia Tech have embraced ... Read more
Women have all the more reason to eat a healthy diet and to exercise regularly in order to maintain normal weight and insulin levels. A study from Imperial College London ... Read more
Researchers from the Wellcome Trust Sanger Institute have identified a new gene linked to triple negative breast cancer (TNBC), which has one of the poorest prognoses and describes 20% of ... Read more
Researchers at the University of California, Los Angeles (UCLA) have harnessed the power of large and expensive microscopes for cancer detection into the world’s first lens-free microscope. The device can ... Read more
Certain common DNA variations, called polymorphisms, can determine how tumor progression evolves in breast cancer and other types of cancers, including ovarian cancer. Researchers at The Wistar Institute, led by ... Read more
An experimental drug known as palbociclib, developed by Pfizer, Inc. and tested at the Revlon/UCLA Women’s Cancer Research Program in UCLA’s Jonsson Comprehensive Cancer Center (JCCC), extended progression-free survival of ... Read more
Despite clinical recommendations against using Cytochrome P450 2D6 (CYP2D6) gene expression as a guide for tamoxifen therapy for breast cancer patients, a study from the Mayo Clinic suggests otherwise. The ... Read more
Despite the utility of certain biomarkers in predicting triple negative breast cancer outcomes after chemotherapy treatment, it appears as though the level of tumor-infiltrating lymphocytes (S-TILs) cannot predict the outcome ... Read more
// Fill in your MailChimp popup settings below.
// These can be found in the original popup script from MailChimp.
var mailchimpConfig = {
baseUrl: 'mc.us5.list-manage.com',
uuid: '52c64784d386bd00ea57ee792',
lid: 'ea3614260e'
};
// No edits below this line are required
var chimpPopupLoader = document.createElement("script");
chimpPopupLoader.src = '//s3.amazonaws.com/downloads.mailchimp.com/js/signup-forms/popup/embed.js';
chimpPopupLoader.setAttribute('data-dojo-config', 'usePlainJson: true, isDebug: false');
var chimpPopup = document.createElement("script");
chimpPopup.appendChild(document.createTextNode('require(["mojo/signup-forms/Loader"], function (L) { L.start({"baseUrl": "' + mailchimpConfig.baseUrl + '", "uuid": "' + mailchimpConfig.uuid + '", "lid": "' + mailchimpConfig.lid + '"})});'));
jQuery(function ($) {
//document.body.appendChild(chimpPopupLoader);
//$(window).load(function () {
// document.body.appendChild(chimpPopup);
});
});
